Рак молочной железы и беременность (особенности клиники, диагностики и лечения, прогноз)
Диссертация
Различные комбинации противоопухолевого лечения при РМЖ, включающего лучевую терапию, химиотерапию, непосредственно влияют на овариальную функцию пациентки, вызывая снижение запасов ооцитов, овариального резерва. С одной стороны, необходимость контролировать функцию яичников определяется общими задачами лечения гормонозависимых опухолей. С другой стороны, определяется возрастающий интерес… Читать ещё >
Содержание
- СПИСОК СОКРАЩЕНИЙ РАЗДЕЛ I. СОВРЕМЕННЫЕ ВЗГЛЯДЫ НА ЭТИОЛОГИЧЕСКИЕ, ПАТОГЕНЕТИЧЕСКИЕ МЕХАНИЗМЫ, ТЕЧЕНИЕ, ПРОГНОЗ И МЕТОДЫ ЛЕЧЕНИЯ РАКА МОЛОЧНОЙ ЖЕЛЕЗЫ, СВЯЗАННОГО С
- БЕРЕМЕННОСТЬЮ (ОБЗОР ЛИТЕРАТУРЫ)
- 1. 1. Эпидемиология
- 1. 2. Классификаци я
- 1. 3. Этиология и патогенез
- 1. АКлиническая диагностика
- 1. 5. Инструментальная диагностика
- 1. 6. Лабораторные исследования
- 1. 7. Дифференциальная диагностика
- 1. 8. Верификация диагноза
- 1. 9. Особенности патоморфологических и молекулярно-биологических характеристик опухоли
- 1. 10. Общие принципы лечения
- 1. 11. Выключение функции яичников и последующее гормональное лечение
- 1. 12. Лечебная тактика с учетом срока беременности
- 1. 13. Прерывание беременности как лечебный фактор
- 1. 14. Метастазы рака молочной железы в плаценту и ткани плода
- 1. 15. Лактация во время и после лечения
- 1. 16. Прогноз при
- РМЖСБ РАЗДЕЛ II. МАТЕРИАЛЫ И МЕТОДЫ
- Глава 2. 1.Дизайн исследования. Общая характеристика пациенток
- Глава 2. 2.Общие методы исследования
- Глава 2. 3.Лабораторная диагностика
- Глава 2. 4.Варианты лечения и их оценка
- Глава 2. 5.Статистический анализ исследуемогоi материала
- РАЗДЕЛ III. СРАВНИТЕЛЬНАЯ ХАРАКТЕРИСТИКА АНАМНЕСТИЧЕСКИХ, ДИАГНОСТИЧЕСКИХ, КЛИНИЧЕСКИХ И
- ГЕОМОРФОЛОГИЧЕСКИХ ОСОБЕННОСТЕЙ РМЖСБ
- Глава 3. 1 .Анамнестические особенности РМЖСБ
- Глава 3. 2.Диагностические особенности РМЖСБ
- Глава 3. 3.Клинические особенности РМЖСБ
- Глава 3. 4.Морфологические особенности РМЖСБ
- Глава 3. 5.Сложности диагностики РМЖСБ
- Мастит и рак молочной железы
- РАЗДЕЛ IV. -ВАРИАНТЫ И РЕЗУЛЬТАТЫ ЛЕЧЕНИЯ БОЛЬНЫХ РМЖСБ
- Глава 4. 1.Комбинированное и комплексное лечение больных
- РМЖСБ РАЗДЕЛ V. ПРОГНОЗ РМЖСБ В ЗАВИСИМОСТИ ОТ АНАМНЕСТИЧЕСКИХ ДАННЫХ, КЛИНИЧЕСКИХ И
- ПАТОМОРФОЛОГИЧЕСКИХ ХАРАКТЕРИСТИК ОПУХОЛИ Глава
- 5. 1. Выживаемость больных РМЖСБ в сравнении с контрольной группой. Общие тенденции
- Глава.
- 5. 2. Выживаемость больных РМЖСБ в зависимости от стадии заболевания
- Глава 5. 3.Прогноз РМЖСБ в зависимости от данных анамнеза
- Глава 5. 4.Прогноз РМЖСБ в зависимости от клинических и патоморфологических данных
- РАЗДЕЛ VI. МОЛЕКУЛЯРНО-БИОЛОГИЧЕСКИЕ ОСОБЕННОСТИ РМЖСБ
- Глава 6. 1.Генетические особенности РМЖСБ
- Глава 6. 2.Связь MMTV-родственного ретровируса с РМЖ, диагностированного на фоне беременности и лактации
- РАЗДЕЛ VII. БЕРЕМЕННОСТЬ КАК ФАКТОР, ВЛИЯЮЩИЙ НА ПРОГНОЗ И ТЕЧЕНИЕ РАКА МОЛОЧНОЙ ЖЕЛЕЗЫ Глава
- 7. 1. Влияние временного интервала от даты родов до даты постановки диагноза РМЖ на течение и прогноз заболевания
- Глава.
- 7. 2. Влияние последующей беременности при раке молочной железы на течение и прогноз заболевания
- РАЗДЕЛ УШ. РЕПРОДУКТИВНАЯ ФУНКЦИЯ БОЛЬНЫХ РМЖ
- СПОСОБЫ ЕЕ СОХРАНЕНИЯ И ВОССТАНОВЛЕНИЯ
- Глава 8. 1.Репродуктивная функция больных РМЖ после комбинированного лечения
- Глава 8. 2.Применение современных репродуктивных технологий у больных
- Глава 8. 3.Рак молочной железы и программа экстракорпорального оплодотворения (ЭКО)
Список литературы
- Адамян Л.В., Жордания К. И., Белобородов С. М. Репродуктивная функция у онкологических больных. Как сохранить возможность иметь детей // Вопросы онкологии- 2004. т.50. -№ 3. С. 279−292.
- Э.К. Айламазян, В. И. Кулаков, В. Е. Радзи некий, Г. М. Савельева. М.: ГЭОТАР-Медиа, 2007. — С. 376.
- Берштейн Л.М. Гормональный канцерогенез. СПб.: Наука, 2000. — 199 с.
- Боровская Т.Г., Гольдберг В. Е. Овариотоксичность цитостатических препаратов и способы ее фармакологической коррекции. — Томск: Изд. Томского универ., 2007. С. 60−81.
- Боярский К.Ю. Старение репродуктивной системы и результативность вспомогательных репродуктивных технологий // Проблемы репродукции. — 1996. т.2. -№ 4. С. 57−62.
- Воротников И.К. Неэпителиальные и фиброэпителиальные опухоли молочных желез. Клиника, диагностика, лечение: Дис. д-ра мед. наук. — М., 2000.
- Габуния М.С. Репродуктивное здоровье женщин и состояние молочных желез: Дис. д-ра мед. наук.-М., 2001.
- Давыдов М.И., Аксель Е. М. Заболеваемость злокачественными новообразованиями населения России и стран СНГ в 2004 г. // Вестник РОНЦ им. Н. Н. Блохина РАМН. 2006.-т. 17. — № 3 (прил.1). — С. 45−77.
- Двенадцатова О.И. Влияние гормональной терапии на состояние молочных желез в циклах индукции овуляции у женщин с бесплодием, обусловленным СПКЯ. Автореф. дис. канд. мед. наук. Москва, 2003.
- Дымарский Л.Ю. Рак молочной железы ильман В.М. Четыре модели медицины. М: Медицина, 1980. — 37−38 с.
- Ермилова В.Д., Соколова И. Т. Лекарственный патоморфоз рака молочной железы // Арх.патологии. 1980. — № 6. — С. 9−13.
- Ермилова В. Д. Патоморфологическая характеристика опухолей и опухолеподобных заболеваний молочной железы // Клиническая маммология / Под ред. Камповой-Полевой Е.Б., Чистякова С. С. «Гиотар-Медиа», 2006. — С. 17−48.
- Жулев Н.М. Диагностика и лечение миастении // Научные труды IX Всерос. Съезда неврологов. Ярославль, 2006. — 104 с.
- Зайрагьянц О.В. Гигантомастия при беременности, развившейся на фоне тимико-лимфатического состояния // Арх.патологии. — 1986. № 7. — С. 87−91.
- Ильин А.Б., Бескровный С. В. Молочная железа как орган репродуктивной системы женщины. // Акушерство и женские болезни. 2000. — № 2. — С. 51−52.
- Кампова-Полевая Е. Б. Рак молочной железы у молодых женщин: Дис. канд. наук. Москва, 1975.
- Карпова Г. В., Боровская Т. Г., Тимина Е. А. с соавг. Реакции системы красной крови (эритрона) в отдаленные сроки после воздействия карбоплатина у беременных крыс // Эксперим. и клин, фармакология. 2004. — Т. 67. — № 2. — С. 38−40.
- Крюкова И.Н., Лушникова А. А., Маливанова Т. Ф. О возможном участии ретровирусов в индукции рака молочной железы человека // Вопросы вирусологии. 2002. — № 4. — С. 4−9.
- Кулаков В.И., Прилепская В. Н. Практическая гинекология (клинические лекции). -М.: МЕДпресс-информ. -2001.
- Лавникова Г. А. Некоторые закономерности лучевого патоморфоза опухолей человека и их практическое использование // Вестник АМН СССР. — 1976.-№ 16.-С. 13−19.
- Левков Л. Криоконсервирование овариальной ткани* человека: современное состояние // Современные возможности вспомогательных репродуктивных технологий: Тезисы докладов научно-практической конф. 29 сентября 2006 г. Санкт-Петербург, 2006. — С. 23−24.
- Лечение местнораспространенного рака молочной железы // Рак молочной железы / Под ред. Кушлинского Н. Е, Портного С. М., Лактионова К. П. М.: РАМН, 2005. — С. 325−326.
- Лукьянченко А.Б., Гурова Н. Ю. Радиология —Практика. 2001. — № 3. — С. 3−9.
- Лушников Е. Ф. Лечебный патоморфоз опухолей // Паталогоанатомическая диагностика опухолей человека / Под ред. Краевского Н. А., Смолянникова А. В., Саркисова Д. С. 4-е изд. — М.: Медицина, 1993. — 560 с.
- Лушникова А. А, Крюкова Н. И., Ротин Д. Л., Любченко Л. Н. Обнаружение последовательностей, гомологичных гену env MMTV, в лимфоидной ткани кишечника больной раком молочной железы // Докл. Акад. Наук. 2004. — Т. 399.-№ 1.-С. 118−121.
- Лушникова А.А., Крюкова И. Н., Пароконная А. А. и др. Обнаружение env MMTV-гомологичных последовательностей у беременных и кормящих женщин с опухолями молочных желез // Молекулярн. медицина. — 2006. — № 1. С. 4853.
- Лушникова А.А. MMTV и канцерогенез молочных желез у человека // Молекулярн. медицина. 2007. — № 4. — С. 19−26.
- Любченко Л.Н. Генодиагностика наследственной предрасположенности к раку молочной железы и разработка системы индивидуального прогнозирования развития, течения и профилактики заболевания: Ав-тореф. дис. канд. мед. наук. — Москва, 2002.
- Любченко Л.Н., Портной С. М., Поспехова Н.И и др. Клинико-молекулярные аспекты наследственного рака молочной железы // Молекулярн. медицина. 2007.-№ 1.-С. 8−14.
- Малыгин Е.Н., Бутина М. Н. Проблема макромастии: клиника, диагностика, лечение // Гинекология. 1999. — Т 1. — № 2. — С. 7−11.
- Манухин И.Б., Тумилович Л. Г., Геворкян М. А. Клинические лекции по гинекологической эндокринологии. — М.: МИА. — 2001. — 26−31 с.
- Марченко Л.А., Александрова Н. В. Роль представителей семейства трансформирующего фактора роста beta в оценке овариального резерва у женщин с преждевременной недостаточностью яичников // Гинекология. — 2006.-Т. 8.-№ 1.
- Моисеенко Е.И., Заева Г. Е., Озолин Г. Е. с соавт. Показатели здоровья новорожденных лиц родителей, в детстве излеченных от злокачественных новообразований // Материалы VI Всесоюзного съезда онкологов. — Ростов на Дону, 2005.-Т. 2.-55 с.
- Назаренко Т.А., Смирнова А. А. Индукция моно- и суперовуляции: оценка овариального резерва, ультразвуковой и гормональный мониторинг // Проблемы репродукции. 2004. — № 1. — С. 36−42.
- Петров Ю.В. Рак молочной железы. М.: Медицина, 1964. — С. 176−182.
- Полевая Е.Б., Портной С. М. Рак молочной железы и беременность // Материалы V Ежегодной российской онкологической конференции. — Москва, 27—29 ноября 2001 г. 36−38 с.
- Святухина О.В. Комплексная терапия далеко зашедшего рака молочной железы: Дис. д-ра мед. наук. — Москва, 1965.
- Сметник В.П. Половые гормоны и молочная железа. // Гинекология. -2000.-№ 2(5).-С. 133−136.
- Сметник В.П., Тумилович Л. Г. Неоперативная гинекология. М., 2001. С. 556−575.
- Справочник по классификации злокачественных опухолей. Официальные рекомендации Американской объединенной комиссии по злокачественным новообразованиям: Перевод с англ. С.-Пб.: Медакадемия, 2007. — С. 241−255.
- Шафеи Р.А., Милаев С. Г. Эмбриологические аспекты витрификации эмбрионов человека // Репродуктивные технологии сегодня и завтра: Материалы XV международной конференции 8−10 сентября 2005 г. — Чебоксары, 2005.-С. 107−108.
- Addis A., Schuler-Faccini L. Chemotherapy in pregnancy // Motherisk Guide to Cancer in Pregnancy and Lactation. 2005. — P. 61−115.
- Aebi S., Loibl S. Breast Cancer during pregnancy: medical therapy and prognosis // Recent Results Cancer Res. 2008. — Vol. 178. — P. 45−55.
- Agnarsson В., Jonasson J., Bjomdottir I. et al. Inherited BRCA 2 mutation associated with high grade breast cancer // Breast Cancer Res Treat. 1998. — Vol.47.-P. 121−127.
- Ahn В., Kim H., Moon W. et al. Pregnancy and lactation associated breast cancer: mammographic and sonographic findings // J Ultrasound Med, 2003. Vol. 22.-P. 491−499.
- Alvarado M.V., Russo I.H., Russo J.J. Histochem And Cytochem // Breast Cancer Res Treat. 1992. — Vol. 41. — P. 29−34.
- Anderson В., Petrek J., Byrd D., Senie R., Borgen P. Pregnancy influences breast cancer stage at diagnosis in women 30 years of age and younger // Ann. Surg. Oncol., 1996. Vol. 3. — P. 204−211
- Antypas C., Sandilos P., Kouvaris J. Fetal dose evaluation during breast cancer radiotherapy // Int. J. Radiat. Oncol. Biol. Phys., 1998. Vol. 40. — P. 995−999.
- Applewhite R., Smith L., Di Vincenti F. Carcinoma of the breast associated with pregnancy and lactation // Am Surg., 1973. Vol. 39. — P. 101−104.
- Ariel I., Kempner R. The prognosis of patients who become pregnant after mastectomy for breast cancer // Int Surg., 1989. Vol. 74. — P. 185−187.
- Aubard Y., Piver P., Pech J.C. et al. Ovarian tissue cryopreservation and gynecologic oncology: a review // Europ. J. Obstet. Gyn. 2001. — Vol. 91. — P. 5−14.
- Aviles A., Neri N. Hemotological malignancies and pregnancy: a final report of 84 children who received chemotherapy in utery // Clin Lym., 2001. Vol. 2. — P. 73−77.
- Ayhan A., Coskun A.S., Celik H. et al. Association between fertility drugs and gynecologic cancers, breast cancer, and chi ldhood ca ncers // Acta Obstetricia et Gynecologica Scandinavica, 2004. Vol. 83 (12).
- Baker J., Ali A., Groch M., Fordham E., Economou S. Bone scanning in patients with breast carcinoma// Clin Nucl Med. 1987. — Vol. 12. — P. 519−524.
- Ball J., Fox K.R. Age-associated incidence of chemotherapy-related amenorrhea following adjuvant doxorubicin, ciclophosphamide, and paclitaxel in early-stage breast cancer // Proc. Am. Soc. Clin. Oncol., 2001. Vol. 20 (16b). — abs. 1810.
- Bannadonna G., Valgussa P. Adjuvant systemic therapy for resectable breast cancer. // J. Clin. Oncol., 1985. Vol. 3. — P. 259−275.
- Barnovan Y., Wallack M.K. Management of the pregnant patient with carcinoma of the breast // Surg. Gynecol. Obstet., 1990. Vol.171. — P. 347−352.
- Bernstein L., Hanisch R., Sullivan-Halley J. et al. Treatment with human chorionic gonadotropin and risk of breast cancer // Cancer Epidemiol Biomarkers Prev., 1995. Vol. 4. — P. 437−440.
- Berry D.L., Theriault R.L., Holmes F.A. et al. Management of breast cancer during pregnancy using a standardized protocol. // J. Clin. Oncol., 1999. Vol.17. — P.855−861
- Bines J., Oleske D. M et al. Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer. // J. Clin. Oncol., 1996. Vol. 14. — P. 1718−1729.
- Birch J., Alston R., McNally R. et al. Relative frequency and morphology of cancers in carriers of germline TP53 mutations // Oncogene, 2001. Vol.20. — P. 4621−4628.
- Bock K., Hadji P., Ramaswamy A., Schmidt S., Duda V.F. Rationale for a diagnostic chain in gestational breast tumor diagnosis. // Arch Gynecol Obstet, 2006. -Vol. 273.-P. 337−459.
- Bodner-Ader В., Bodner K., Zeisler H. Breast cancer diagnosed during pregnancy // Anticancer Res., May-Jun 2007. Vol. 27(3B). — P. 1705−1707.
- Bokser L., Szende В., Schally A. Protective effects of D-Trp6-luternising hormone microcapsules against ceclophosphamide-induced gonadotovicity in female //Br.J.Cancer, 1990. Vol. 6. — P. 61−865.
- Bonnier P., Romain S., Dilhuydy J. et al. Influence of pregnancy on the outcome of breast cancer: a case-control study. // Int. J. Cancer, 1997. Vol. 72. — P. 720−727.
- Braga C., Negri E., La Vecchia C. et al. Fertility treatment and risk of breast cancer. //Hum. Reprod., 1996. Vol. 11. — P. 300−303.
- Brenner R.J., Bassett L.W., Fajardo L.L. et al. Stereotactic core-needle breast biopsy: a multi-institutional prospective trial. // Radiology, 2001. Vol. 218. — P. 866−872.
- Brinton L. & S.Devesa. Incidence, Demographics, and Enviromental Factors. In: Harris J., Morrow M., Lippman M., et al. Diseases of the Breast //Lippincott-Raven Publishers: Philadelphia, 1996.- P. 159−168.
- Brinton L., Scoccia В., Moghissi K.,.Westhoff C. et al. Breast cancer risk associated with ovulation stimulating drugs // Human Reproduction, 2004. Vol. 19. — № 9. — P. 2005−2013.
- Brinton L.A., Schairer C., Hoover R.N. et al. Menstrual factors and risk of breast cancer. // Cancer Invest, 1988. Vol. 6. — P. 245−254.
- Britt A., Ashworth A., Smalley M. Pregnancy and the risk of breast cancer // Endocr. Rellat. Cancer, 2007. Vol. 14. — № 4. — P. 907−933.
- Bruzzi P., Negri E., La Vecchia C. et al. Short term increase in risk of breast cancer after full term pregnancy. // BMJ, 1988. Vol. 297. — P. 1096−1098.
- Brzezinski A., Peretz Т., Mor-Yosef S. et al. Ovarian stimulation and breast cancer: Is there a link? // Gynecol Oncol, 1994 Vol. 52. — P. 292−295.
- Bunker M., Peters M. Breast cancer associated with pregnancy or lactation // Am. J. Obstet. Gynecol., 1963.-Vol. 85.-P. 312−321.
- Burstein H., Winer E. Reproductive issues in breast cancer patients // In Diseases of the Breast. 2nd edition. Philadelphia: Lippincott-Williams&Wilkins. — P. 1051−1059.
- Byrd B.J., Bayer D., Robertson J. Treatment of breast tumors associated with pregnancy and lactation // Ann. Surg., 1962. Vol. 155. — P. 940−947.
- Cardonick E., Iacobucci A. Use of chemotherapy during human pregnancy // Lancet oncol., 2004. Vol. 5. — P. 283−291.
- Carol E.H., Conner S., Schorr S. The diagnosis and management of breast problems during pregnancy and lactation //Am. J. Surg., 1995. Vol. 170. — P. 401 404.
- Cheli C., Moms D., Neaman I., Dai J., Allard W., Yeung K. Measurement of four tumor marker antigens in the sera of pregnant women // J. Clin. Lab. Anal., 1999.-Vol. 13.-P. 35−39.
- Chie W.C., Hsieh C., Newcomb P.A. Age at any full-term pregnancy and breast cancer risk//Am. J. Epidemiol, Aprl 2000. Vol. 151(7). — P. 715−722.
- Ciatto S., Pacini P., Azzini V. et al. Preoperative staging of primary breast cancer: a multicentric study // Cancer, 1988. Vol. 61. — P. 1038−1040.
- Clark R.M., Chua T. Breast cancer and pregnancy: the ultimate chellenge // Clin. Oncol., 1998.-Vol. 1.-P. 11−18.
- Clark R.M., Reid J. Carcinoma of the breast in pregnancy and lactation // Int. J. Radiat. Oncol. Biol. Phys., 1978. Vol. 4. — P. 693−698.
- Cnattingius S., Torrang A., Ekbom A., Granath F., Petersson G., Lambe M. Pregnancy characteristics and maternal risk of breast cancer // JAMA, Mar 8 2006. — Vol. 295 (10).-P. 1124−1125.
- Cobo A. Oocyte cryopreservation // Internat. Sympos. Cancer and reproduction. — Valencia, March 25−27 2007.
- Colbeigh M.A., Bines J., Lincoln S.T. et al. Amenorrea following adjuvant chemotherapy for breast cancer // Proc. Am. Soc. Clin. Oncol., 1994. Vol. 13. — P. 63, abst. 55.
- Colleoni M, Rotmensz N, Robertson C, Orlando L, Viale G, Renne G, Luini A, Veronesi P, Intra M, Orecchia R, et al. Very young women (<35 years) with operable breast cancer: features of disease at presentation // Ann Oncol., 2002.- Vol.13. — P.273−279.
- Cooper D.R., Butterfield J. Pregnancy subsequent to mastectomy for cancer of the breast//Ann. Surg., 1970. Vol. 171. — P. 429−433.
- Copeland L.J., London M.B. Malignant disease and pregnancy. In: Gabbe S et al editors., Fourth edition: Obstetrics, Normal and Problem Pregnancies. -Philadelphia: Churchill Livingston. -2000. P. 1255−81.
- Couch F. J. et al. BRCA 1 mutations in women attending clinics that evaluate the risk of breast cancer//N. Engl. J. Med., 1997. Vol.336. — P. 1409−1415.
- Crosby C.H., Barclay T.H.C. Carcinoma of the breast: surgical management of patients with special conditions // Cancer, 1971. Vol. 28. — P. 1628−1636.
- Cullins S.L., Pridjian G., Sutherland C.M. Goldenhar’s syndrome associated with tamoxifen given to the mother during gestation letter. // JAMA, 1994. Vol. 271.-P. 1905−1906.
- Danforth D. R, Arbogast L. K, Friedman C.I. Acute depletion of murine primordial follicle reserve by gonadotropin-releasing hormone antagonists // Feitil Steril., -2005. -Vol.83. P. 1333−1338.
- Daling J., Malone K., Doody D. et al. The Relation of Reproductive Factors to Mortality from Breast Cancer // Cancer Epidemiology, Biomarkers & Prevention, March 2002. Vol. 11. P. 235−241.
- Danforth D.N. Breast cancer during pregnancy // Theriault R.(Review) Oncology (Huntington), 2001. Vol. 15 (1). — P. 39−46.i
- Dargent M. Cancer du sein et grossesse elements du prognostic // Bull. Cancer, 1959.-Vol. 46.-P. 666−682.
- Davis F.L., Klitus M., Mintzer D.M. Chemotherapy-inducer amenorrhea from adjuvant breast cancer treatment: the effect of the addition of taxanes // Clin. Breast Cancer, 2005. Vol. 6. -№ 5. — P. 421−424.
- Deemarsky L.J., Neishtadt E.L. Breast cancer and pregnancy // Breast, 1980. — Vol. 7.-P. 17−21.
- Del Mastro L., Catzeddu Т., Boni L. Prevention of chemotherapy-induced menopause by temporary ovarian suppression with goserelin in young, early breast cancer patients // Annals of Oncol., 2006. Vol. 17. — № 1. — P. 74−78.
- Devitt J.E., Beattie W.G., Stoddart T.G. Carcinoma of the breast and pregnancy//Can. Surg., 1964.-Vol. 7.-P. 124−128.
- Diethelm L., Xu H. Diagnostic imaging of the lung during pregnancy // Clin. Obstet. Gynecol., 1996. Vol. 39. P. 36−55.
- Doll D., Ringenberg Q., Yarbro J. Antineoplastic agents and pregnancy // Semin. Oncol., 1989. Vol. 16. P. 337−346.
- Donegan W.L. Breast cancer and pregnancy // Obstet Gynecol., 1977. Vol. 50. -P. 244−252.
- Donnez J., Dolmans M.M., Demylle D. et al. Livebirth after orthotopic transplantation of cryopreserved ovarian tissue // Lancet. Vol. 364.-P. 1405−1410.
- Dor J., Lerner-Geva L., Rabinovici J. et al. Cancer incidence in a cohort of infertile women who underwent in vitro fertilization // Fertil Steril, 2002. — Vol. 77. — P. 324−327.
- Doyle P., Maconochie N., Beral V. Cancer incidence following treatment for infertility at a clinic in the UK // Human Repr., 2002. Vol. 17. — № 8. — P. 22 092 213.
- Dunn L, Fox KR. Techniques for fertility preservation in patients with breast cancer// Curr. Opin. Obstet. Gynecol., 2009.. -Vol. 21(1). -P.:68−73.
- Duncan P.G., Pope W.D.B., Cohen M.M. et al. Fetal risk of anesthesia and surgery during pregnancy // Anesthesiology, 1986. № 64. — P. 790−794.
- Dunn J.J., Anderson C., Brost B. Breast carcinoma metastatic to the placenta // Obstet Gynecol., 1999. Vol. 94. — P. 846.
- Ebert U., Loffler H., Kirch W. Cytotoxic therapy and pregnancy // Pharmacol. Ther., 1997. Vol. 74. — P. 207−220.
- Ehman R., Crues J., Lenkinski R. et al. Magnetic resonance // Radiology, 1996. -Vol. 198.-P. 920−926.
- Ekbom A., Trichopoulos D., Adami H.O. et al. Evidence of prenatal influences on breast cancer risk // Lancet, 1992. Vol. 340. — P. 1015−1018.
- Elledge R, Ciocca D, Langone G, McGuire W. Estrogen receptor, progesterone receptor and HER-2/neu protein in breast cancers from pregnant patients//Cancer, 1993.-Vol. 71.-P. 2499−2506.
- Elster A.D. Does MR imaging have any known effects on the developing fetus? // Am. J. Roentgenol., 1994. Vol. 162. — P. 1493.
- Epstein R. Adjuvant breast cancer chemotherapy during late-trimester pregnancy: not quite a standard of care // BMC Cancer, 2007. — Vol. 7. P. 92.
- Eun Ju Son, Ki Keun Oh, Eun Kyung Kim. Pregnancy-associated breast disease: radiologic features and diagnostic dilemmas // Yonsei Med. J., 2006. Vol. 47. -№ l.-P. 34−42.
- Faddy M., Gosden R. A mathematical model of follicle dynamics in the human ovary // Human Reprod., 1995. Vol. 10. — P. 770−775.
- Faddy MJ, Gosden RG. A model confirming the decline in follicle numbers to the age of menopause in women. //Hum Reprod., 1996. — Vol.11.- P.: 1484−1486.
- Falkenberry S.S. Breast cancer in pregnancy (review) // Obstet Gynecol. N. Am., 2002. Vol. 29 (1). — P. 225−232.
- Fancin R., Schonauer L.M. et al. Serum anti-Mullerian hormone is more strongly related to ovarian follicular status than inhibin B, estradiol, FSH and LH on day 3 //Hum. Reproduct., 2003. Vol. 18 (2). — P. 323−327.
- Faschinger A., Rouault F., Sollner J. et al. Mouse mammary tumor virus integration site selection in human and mouse genomes // J. Virol., Nov. 21 2007. — P. 324−348.
- Fenig E., Mishaeli M., Kalish Y., Lishner M. Pregnancy and radiation // Cancer Treat Rev., 2001.-Vol. 27.-P. 1−7.
- Fiorica J. Special problems: breast cancer and pregnancy // Obstet Gynecol. Clin. North Am, 1994.-Vol. 21.-P. 721−732.
- Ford D, Easton D, Bishop D. et al. Consortium BCL. Risk of cancer in BRCA 1 mutaftion carriers // Lancet, 1994. — Vol. 343. — P. 692−695.
- Ford D., Easton D., Stratton M. et al. Genetic heterogeneity and penetrance analysis of the BRCA 1 and BRCA 2 genes in breast cancer families // Am. J. Hum. Genet., 1998. Vol. 62. — P. 676−689.
- Former M.N., Modi S., Hudis C.A. Incidenceof amenorrhea in breast cancer patients<40 years of age after paclitaxel-based adjuvant chemotherapy // Breast Cancer Research Treatment, 2002. Vol. 76 (1). — abs. 645.
- Gallenberg M., Loprinzi C. Breast cancer and pregnancy // Semin. Oncol., 1989.-Vol. 16. P. 369−376.
- Garel C., Brisse H., Sebag G., Elmaleh M., Oury J., Hassan M. Magnetic resonance imaging of the fetus // Pediatr. Radiol., 1998. Vol. 28. — P. 201−211.
- Gauthier E., Paoletti X., Clavel-Chapelon F. Breast cancer risk associated with being treated for infertility: results from the French E3N cohort study // Human Reproduction, 2004. Vol. 19 (10). — P. 2216−2221.
- Gelber S., Coates A., Goldhirsch A. et al. Effect of pregnancy on overall survival after the diagnosis of early-stage breast cancer // Clin. Oncol., 2001. Vol. 19.-P. 1671−1675.
- Gemignani M.L., Petrek J.A. Pregnancy after breast cancer // Cancer Control., May 1999. Vol. 6 (3). — P. 272−276.
- Gemignani M.L., Petrek J.A., Borgen P.I. Breast cancer and pregnancy // Surg. Clin. North Am., 1999.-Vol. 79. -№ 5.-P. 1157−1169.
- Gentilini O., Cremonesi M., Trifiro G. et al. Safety of sentinel node biopsy in pregnant patients with breast cancer // Ann. of Oncol., 2004. Vol. 15(9). — P. 13 481 351.
- Gentilini O., Masullo M., Rotmensz N. et al. Breast cancer diagnosed during pregnancy and lactation: biological features and tretment options // Eur. J. Surg. Oncol., Apr. 2005. Vol. 31 (3). — P. 232−236.
- Gentilini O. Breast cancer during pregnancy: epidemiology, surgical treatment, and staging // Recent Results Cancer Res., 2008. Vol. 178. — P. 39−44.
- Gerber В., Dieterich M., Mtiller H., Reimer Т. Controversies in preservation of ovary function and fertility in patients with breast cancer // Breast Cancer Research and Treatment, April 25 2007. Vol.5. — P. 200−214.
- Gilliland FD, Hunt WC, Baumgartner KB, Crumley D, Nicholson CS, Fetherolf J, Sarnet JM. Reproductive risk factors for breast cancer in Hispanic and non-Hispanic white women. // Am J Epidemiol. 1998. Vol.148. — P.683−92.
- Giacalone P.L., Laffargue F., Benos P. Chemotherapy for breast carcinoma in pregnancy: a French national survey // Cancer, 1999. Vol. 86. — P. 2266−2272.
- Gibbs C.P., Hawkins J.L. Nonobstetric surgery during pregnancy // ASA Refresher Courses on Anesthesiology, 1994. — Vol. 22. — Ch.10.
- Greene F.L. Gestational breast cancer: a ten-year experience // South Med., 1988,-Vol. 81.-P. 1509−1511.
- Greskovich J.J., Macklis R. Radiation therapy in pregnancy: risk calculation and risk minimization // Semin. Oncol., 2000. Vol. 27. — P. 633−645.
- Gross S.W. A practical Treatise on tumors of the mammary gland: embracing their histology, pathology, diagnosis and treatment // N.-Y., 1880.
- Guinee V.F., Olsson H., Miller T. et al. Effect of pregnancy on prognosis for young women with breast cancer // Lancet, Jun 25 1994. — Vol. 343(8913). — P. 1587−1589.
- Gwyn K. Children exposed to chemotherapy in utero // J. Natl. Cancer Inst. Monographs, 2005. Vol. (34). — P. 69−71.
- Gwyn K., Theriault R. Breast cancer during pregnancy // Oncology (Huntingt), 2001.-Vol. 15.-P. 39−46.
- Haagensen C.D., Staut A.P. Carcinoma of the breast, criteria of operability // Ann. Surg., 1943.-Vol. 118.-P. 859−863.
- Haagersen C.D. Cancer of the breast in pregnancy and during lactation // Amer.J. Obstet Gynecol., 1967.-Vol. 96.-P. 141−149.
- Haffty В., Harrold E., Khan A. et al. Outcome of conservatively managed early-onset breast cancer by BRCA½ status // Lancet, Apr 27 2002. Vol. 359 (9316).-P. 1471−1477.
- Hanrahan E.O., Theriault R.L. Pregnancy and Breast Cancer // In «Breast Cancer» second edition by D.J. Winchester, D.P. Winchester, C.A. Hudis, L. Norton, ВС Decer Inc, Hamilton, 2006. P. 473−486.
- Harold J. et al. Reproductive health in breast cancer patients. — Breast Cancer" second edition by D.J. Winchester, D.P. Winchester, C.A. Hudis, L. L. Norton, ВС Decer Inc, Hamilton, 2006. Chp. 93. P. 1481−1490.
- Harrington S.W. Carcinoma of the breast: results of surgical treatment when the carcinoma occurred in course of pregnancy or lactation and when pregnancy occurred subsequent to operation: 1910−1933 // Ann. Surg., 1937. Vol. 106. — P. 690−700.
- Harris J.R., Morrow M., Lippman M.E. et al. L.A. & S.S.Devesa. Incidence, Demographics, and Environmental Factors, eds.: Diseases of the Breast // Lippincott-Raven Publishers, Philadelphia, 1996. P. 159−168.
- Harvey J.C., Rosen P.P., Ashikari R. et al. The effect of pregnancy on the prognosis of carcinoma of the breast following radical mastectomy // Surg. Gynecol. Obstet., 1981.-Vol. 153.-P. 723−725.
- Heck K.E., Schoendorf K.C., Ventura S.J., Kiely J.L. Delayed childbearing by education level in the United States, 1969−1994 // Matern. Child Health J., 1997. -Vol. l.-P. 81−88.
- Henderson B.E., Ross R.K., Judd H.L. et al. Deregular ovulatory cycles increase breast cancer risk? // Cancer, 1985. Vol. 56. — P. 1206−1208.
- Hensley M.L., Reichman B.S. Fertility and pregnancy after adjuvant chemotherapy for breast cancer // Crit. Rev. Oncol. Hematol., 1998. Vol. 28. — P. 121−128.
- Higgins S., Haffty B. Pregnancy and lactation after breast-conserving therapy for early stage breast cancer // Cancer, 1994. Vol. 73. — P. 2175−2180.
- Hofman S., GE, Oehninger S. et al. Intercycle variability of day 3 follicle-stimulating hormone levels and its effect on stimulation quality in vitro fertilization // Fertil Steril, 1990. Vol. 54. — P. 297−302.
- Holleb A.I., Farrow J.H. The relation of carcinoma of the breast and pregnancy in 283 patients // Surg. Gynecol. Obstet., 1962. Vol. 115. — P. 65.
- Holleb A.I., Farrow J.H. Breast cancer and pregnancy // Acta Unio Int. Contra Cancrum, 1964. Vol. 20. — P. 1480.
- Hoover H.C. Breast cancer during pregnancy and lactation // Surgical Clinics of North America, 1990. Vol. 70 (5). — P. 1151 -1163.
- Hughes D., Ginolthac S., Coupret A. Common BRCA2 variants and modification of breast and ovarian cancer risk in BRCA1 mutation carriers // Cancer Epidemiol. Biomarkers Prev., 2005. Vol. 14(1). — P. 265−267.
- Huisman T.A., Martin E., Kubik-Huch R. et al. Fetal magnetic resonance imaging of the brain: technical considerations and normal brain development // Eur. Radiol, 2002. Vol. 12.-P. 1941−1951.
- Innes K., Byers Т., Schymura M. Birth Characteristics and Subsequent Risk for Breast Cancer in Very Young Women // American Journal of Epidemiology, 2000. -Vol. 152. № 12. — P. 1121−1128.
- Isaacs R., Hunter W., Clark K. Tamoxifen as systemic treatment of advanced breast cancer during pregnancy: case report and literature review // Gynecol. Oncol., 2001.-Vol. 80.-P. 405−408.
- Ishida Т., Yolcoe Т., Kasumi F. et al. Clinicopathological characteristics and prognosis of breast cancer patients associated with pregnancy and lactation: analysis of case-control study in Japan // Jpn. J. Cancer Res., 1992.-Vol. 83.-P. 1143−1149.
- Ives A., Saunders C., Bulsara M., Semmens J. Pregnancy after breast cancer: population based study // BMJ- doi:10.1136/bmj.39 035.667176.55 (8 Dec 2006).
- Jameel A., Jamil S.N. Safety of cytotoxic chemotherapy during pregnancy // J. Рак. Med. Assoc., Sep. 2007. Vol. 57(9). — P. 449−452.
- Jernstrom H., Lerman C., Ghadirian P. et al. Pregnancy and risk of early breast cancer in carriers of BRCA 1 and BRCA2 // Lancet, 1999. Vol. 354(9193). — P. 1846−1850.
- Johannson O., Ranstam J., Borg A. et at. Sunital of BRCA 1 breast and ovarian cancer in patients: apopulation-based studyfrom southern Suleden // J. CUn. Oncol., 1998.-Vol. 16. -№ 1. P. 397−404.
- Johannsson O., Borg A., Olsson IT. Pregnancy-associated breast cancer in BRCA1 and BRCA2 germline mutation carries // Lancet, 1998. P. 1359−1360.
- Joasper MJ, Liebelt J, Hussey ND. Preimplantation genetic diagnosis for BRCA1 exon 13 duplication mutation using linked polymorphic markers resulting in a live birth // Prenat Diagn., 2008. Vol.28. — P. 292−298.
- Jordan V. Effect of tamoxifen on initiation and growth of DMBA-induced rat mammary carcinoma // Eur. J. Cancer, 1976. Vol. 12. — P. 419−424.
- Kaiser H., Nawab E., Nasir A. et al. Neoplasms during the progression of pregnancy (review) // In vivo, 2000. Vol. 114 (1). — P. 277−285.
- Kal H, B" Struikmans H. Breast cancer and pregnancy // Breast, Feb 2008. -Vol. 17(1).-P. 7.
- Kalter H., Warkany J. Congenital malformations I I New England Journal of Medicine, 1983.-Vol. 308.-P. 424−431.
- Karp G., von Oeyen P, Valone F. et al. Doxorubicin in pregnancy: possible transplacental passage // Cancer Treat Rep, 1983. Vol. 67. — P. 773−777.
- Kato S, Pinto M, Carvajal A, Espinoza N. et al. Progesterone increases tissue factor gene expression, procoagulant activity, and invasion in the breast cancer cell line ZR-75−1 //J. Clin. Endocrinol. Metab, 2005. Vol. 90. — P. 1181−1188.
- Keleher A, Theriault R, Gwyn K. et al Multidiciplinary management of breast cancer concurrent with pregnancy // J. Am. Coll. Surg, Jan 2002. Vol. 194(1). — P. 54−64.
- Kelsey J L, Gammon M D, Esther M. Reproductive Factors and Breast Cancer // Epidemiologic Reviews, 1993. Vol. 15. — № 1.
- Key T. Hormones and cancer in humans // Mutat. Res, 1995. Vol. 333. — P. 59−67.
- Kim S.S. Ovarium tissue banking for cancer patients. To do or not to do? // Hum. Reprod, 2003.-Vol. 12.-P. 1028−1031.
- King R, Welch J, Martin J. J, Coulam C. Carcinoma of the breast associated with pregnancy // Surg. Gynecol. Obstet, 1985. Vol. 160. — P. 228−232.
- Klip H, Burger C. W, Kenemans P. et al. Cancer risk associated with subfertility and ovulation induction: a review // Cancer Causes Control, 2000. — Vol. 11.-P. 319−344.
- Knox T. Evaluation of abnormal liver function in pregnancy // Semin. Perinatol, 1998. Vol. 22. — P. 98−103.
- Koren G, Lishner M, Santiago S. The motherisk Guide to Cancer in Pregnancy and Lactation. Canada. -2005. -198 p.
- Kroman N., Jensen M.B., Melby M. et al. Should women be advised against pregnancy after breast-cancer treatment? // Lancet, 1997. Vol. 350. — P. 319−322.
- Kroman N., Wohlfahrt J., Andersen K.W. et al. Parity, age at first childbirth and the prognosis of primary breast cancer // Br. J. Cancer, 1998. Vol. 78. — P. 1529−1533.
- Kuczkowski K.M. Nonobstetric surgery during pregnancy: What are the risk of anesthesia? // Obstet. Gynecol. Surv., 2004. Vol. 59. — P. 52−56.
- Kuerer H.M., Cunningham J.D., Brower S.T., Tartter P.I. Breast carcinoma associated with pregnancy and lactation // Surg. Oncol., 1997. Vol. 6. — P. 93−98.
- Kumle Merethe. Pregnancy and breast cancer // 3rd European Breast Cancer Conference, Barcelona, March 22. 2002.
- Kvale G., Heuch I. Menstrual factors and breast cancer risk // Cancer, 1988. -Vol. 62.-P. 1625−1631.
- Lamattina J.C., Guixa H.G., Lorusso C., Orti R., Nunez de Pierro A.R. Data on breast cancer in pregnancy. // In: Isaacs J.H., editor. Textbook of breast disease St. Louis: Mosby-Year Book, 1992. -P. 319−329.
- Lamp Т., Schultz-Lobmeyr I., Obruca A. et al. Premature ovarian failure: etiology and prospects // Gynecol. Endocrinol., 2000. Vol. 14. — P. 292−302.
- Le Nestour E., Marraoui J., Lahlou N. et al. Role of estradiol in the rise in the follicle-stimulating hormone levels during the lutheal-follicular transition // J. Clin. Endocrinol. Metab., 1993. Vol. 77. — P. 439−442.
- Lee M.M., Donahoe P.K. Muillerian inhibiting substance: a gonadal hormone with multiple functions // Endocr. Rev., 1993. Vol. 14. — P. 152−164.
- Lee S., Schove L., Partridge A. et al. American Society of Clinical Oncology Recommendations on Fertility Preservation in Cancer Patients // J. Clin. Oncol., — Vol. 24.-P. 2917−2931.
- Lerner-Geva L., Keinan-Boker L., Blumstein T. et al. Infertility, ovulation induction treatments and the incidence of breast cancer a historical prospectivecohort of Israeli women I I Breast Cancer Res. Treat., Nov 2006. Vol. 100(2). — P. 201−212.
- Li СЛ., Malone K.E., Daling J.R., Potter J.D. et al. Timing of menarche and first full-term birth in relation to breast cancer risk // Am. J. Epidemiol., Jan 15 2008. -Vol. 167(2).-P. 230−239.
- Liberman L., Giess C., Dershaw D., Deutch В., Petrek J. Imaging of pregnancy-associated breast cancer // Radiology, 1994. Vol. 191. — P. 245−248.
- Licciardi F., Liu H., Rosenwaks Z. Day 3 estradiol serum concentration as prognosticator of ovarian stimulation response and pregnancy outcome in patients undergoing IVF // Fertil Steril, 1995. Vol. 64. — P. 991−994.
- Liede A., Narod S.A. Hereditary breast and ovarian cancer in Asia: genetic epidemiology BRCA1 and BRCA2 // Hum. Mutat., 2002. Vol. 20. — P. 413−424.
- Liehr J.G. Is estradiol a genotoxic mutagenic carcinogen? // Endocr. Rev., 2000.-Vol. 21.-P. 40−54.
- Lower E.E., Blau R., Gazder P. et al. The risk of premature menopause induced by chemotherapy for early breast cancer // J. Womens Health Gend. Based Med., 1999.- Vol. 8.-P. 949−954.
- MacDougall M., LeGrand S., Walsh D. Symptom control in the pregnant cancer patient // Semin. Oncol., 2000. Vol. 27. — P. 704−711.
- Mackay J., Jemal A., Lee N. et al. The cancer atlas // Myriad Editions limited, 2006.-P. 85.
- Mallebre В., Elbert A., Perez-Canto A. Geburtshilfe-Frauenheilkd // DFH, 1996.-Vol. l.-P. 35−40.
- Marcus J., Watson P., Page D. et al. BRCA 2 hereditary breast cancer pbenotype // Breast Cancer Res. Treat., 1997. Vol. 44. — P. 275−277.
- Martin M., Pienlcowslci Т., Maclcey J. et al. Adjuvant docetaxel for node-positive breast cancer//N. Engl. J. Med., 2005. Vol. 352. — P. 2302−2313.
- Mathelin C., Youssef C., Brettes J. Paradoxical interactions between pregnancy and breast cancer // Gynec. Obstet. Fertil, May 2007. Vol. 35(5). — P. 446−456.
- Mattison D., Angtuaco T. Magnetic resonance imaging in prenatal diagnosis // Clin. Obstet. Gynecol., 1988.-Vol. 31.-P. 353−389.
- Max M., Klamer T. Pregnancy and breast cancer // South Med. J., 1983. Vol. 76.-P. 1088−1090.
- Mayr N., Wen B.C., Saw C. Radiation therapy during pregnancy // Obstet Gynecol. Clin. North Am., 1998.-Vol. 25. P. 301−321.
- Mazze R., Kallen B. Reproductive outcome after anesthesia and operation during pregnancy: a registry study of 5405 cases // Am. J. Obstet. Gynecol., 1989. -Vol. 161.-P. 1178−1185.
- McDonnell S., Schaid D., Myers J. et al. Efficacy of contralateral prophylactic mastectomy in women with a personal and family history of breast cancer // J. Clin. Oncol., 2001. Vol. 19(19). — P. 3938−3943.
- McTiernan A., Thomas D.B. Evidence for a protective effect of lactation on risk of breast cancer in young women: results from a case-control study // Am. J. Epidemiol, 1986.-Vol. 124. P. 353−358.
- Meden H., Mielke S., Schauer A., Kuhn W. Serum levels of the c-erbB-2 (HER2/neu) encoded oncoprotein fragment pi05 in normal pregnancies // In Vivo, 1997.-Vol. 11.-P. 51−54.
- Meirow D., Baum M., Yaron R., Levron J., Hardan I., Schiff E., Nagler A., Yehuda D.B. Ovarian tissue cryopreservation in hematologic malignancy: ten years' experience // Leuk Lymphoma, Aug 2007. Vol. 48(8). — P. 1569−1576.
- Meirow D., Levron J., Eldar-Geva T. et al. Pregnancy after transplantation of cryopreserved ovarian tissue in a patient with ovarian failure after chemotherapy // N. Engl. J. Med., 2005.-Vol. 353.-P. 318−321.
- Meirow D., Schiff E. Appraisal of chemotherapy effects on reproductive outcome according to animal studies and clinical data // J. Natl. Cancer Inst. Monographs, 2005. Vol. (34). — P. 21−25.
- Merkel D. Pregnancy and breast cancer // Semin. Surg. Oncol., 1996. Vol. 12.-P. 370−375.
- Michel R. M, Aquilar J. L et al. Human chorionic gonadotropin as an angiogenetic factor in breast cancer during pregnancy. Med. Hypotheses, 2007- 68 (5):1035−40.
- Michels K., Trichopoulos D., Robins J.M. et al. Birth-weight as a risk factor for breast cancer //Lancet, 1996. Vol. 348. — P. 1542−1546.
- Mickal A., Torres J.E., Mule J.G. Carcinoma of breast in pregnancy and lactation//Am. Surg., 1963.-Vol. 29.-P. 509−514.
- Middleton L., Amin M., Gwyn K. et al. Breast carcinoma in pregnant women Assessment of clinicopathologic and immunohistochemical features // Cancer, 2003. Vol. 98.-P. 1055−1060.
- Mignot L., Morvan F., Berdah J. et al. Pregnancy after treated breast cancer: results of a case-control study // Press Med., 1986.-Vol. 15.-P. 1961−1964.
- Miller H.K. Cancer of the breast during pregnancy and lactation // Am. I. Obstet. Cynccol., 1962.-Vol. 83.-P. 607−611.
- Mitre В., Kanbour A., Mauser N. Fine needle aspiration biopsy of breast carcinoma in pregnancy and lactation // Acta Cytol., 1997. Vol. 41. — P. 1121−1130.
- Modan В., Ron E., Lerner-Geva L. et al. Cancer incidence in a cohort of infertile women//Am. J.Epidemiol., 1998.-Vol. 147.-P. 1038−1042.
- Muasher S, Oehninger S, Simonetti S. et al. The value of basal and/or stimulated serum gonadotrophin levels in prediction of stimulation response and IVE outcome // Fertil Steril, 1988. Vol. 50. — P. 298−307.
- Mulvihill JJ, Stewart ICR. A registry of pregnancies exposed to chemotherapeutic agents // Teratology, 1986. Vol. 33. — P. 80.
- Murray C, Reichert J, Anderson J, Twiggs L. Multimodal chemotherapy for breast cancer in the first trimester of pregnancy: a case report // JAMA, 1984. — Vol. 252.-P. 2607−2608.
- National Cancer Institute Breast Cancer and Pregnancy. In: Cancer Topics (2004) / National Cancer Institute. Health Professional. Cited 10 Jan 2007. http://www.cancer.gov/cancertopics/pdq/treatment/breast-cancer-and-pregnancy.
- Navrozoglou I, Vrekoussis T, Kontostolis E, Dousias V, Zervoudis S, Stathopoulos E. N, Zoras O, Paraskevaidis E. Breast cancer during pregnancy: A mini-review // Eur. J. Surg. Oncol, Mar 13 2008. Vol. 2. — P. 260−269.
- Nettleton J, Long J, Kuban D, Wu R, Shaeffer J, El-Mahdi A. Breast cancer during pregnancy: quantifying the risk of treatment delay // Obstet Gynecol, 1996. — Vol. 87.-P. 414−418.
- Newcomb P. A, Egan K. M, Titus-Ernstoff L. et al. PA Lactation and breast cancer risk // J. Mammary Gland Biol. Neoplasia, 1997. Vol. 2, 3. — P. 311−318.
- Newcomb P. A, Storer B. E, Longnecker M.P. et al. Pregnancy Termination in Relation to Risk of Breast Cancer // JAMA, 1996. Vol.275.- P.238.-Ref.43.
- Newcomb P. A, Trentham-Dietz A, Storer B.E. Parental age in relation to risk of breast cancer // Cancer Epidemiol. Biomarkers Prev, 1997. — Vol. 6. P. 151 154.
- Nicklas A, Baker M. Imaging strategies in pregnant cancer patients // Semin. Oncol, 2000. Vol. 27. — P. 623−632.
- Novotny D, Maygarden S, Shermer R, Frable W. Fine needle aspiration of benign and malignant breast masses associated with pregnancy // Acta Cytol, 1991. — Vol. 35.-P. 676−686.
- Nugent P., O’Connell T. Breast cancer and pregnancy // Arch. Surg., 1985. -Vol. 120.-P. 1221−1224.
- Ohayon Т., Gershoni-Baruch R., Papa M. et al. The R72P TP53 mutation is associated with familial breast cancer in Jewish wome // British Journal of Cancer, 2005. Vol. 92. — P. 1144−1148.
- Oktay K, Reh A., Vahdat L. Measuring the impact of chemotherapy on fertility in women with breast cancer // JCO, August 20 2006. Vol. 24. — № 24. — P. 40 444 046.
- Oktay K., Buyuk E., Libertella N. et al. Fertility Preservation in Breast Cancer Patients: A Prospective Controlled Comparison of Ovarian Stimulation With Tamoxifen and Letrozole for Embryo Cryopreservation // J. Clin. Oncol., 2005.
- Oktay K., Economos К., Kan M. et al. Endocrine function and oocyte retrieval after autologous transplantation of ovarian cortical strips to the forearm // JAMA, 2001.-Vol. 286.-P. 1490−1493.
- Oktay K., Karlikaya G. Ovarian function after transplantation of frozen, banked autologous ovarian tissue // N. Engl. J. Med., 2000. Vol. 342. — Pp. 1919.
- Olson S.H., Zauber A.G., Tang J., Harlap S. Relation of time since last birth and parity to survival of young women with breast cancer // Epidemiology, 1998. -Vol. 9.-P. 669−671.
- Pangas S.A., Woodruff Т.К. Activin signal transduction pathways // Trends Endocrinol. Methab., 2000. Vol. 11. — P. 309−314.
- Pappo I. Breast cancer in the elderly: histological, hormonal and surgical characteristics // Breast, 2007. Vol. 16. — P. 60−67.
- Pappo I., Lerner-Geva L., Halevy A. The Possible Association between IVF and Breast Cancer Incidence //Annals of Surgical Oncology, 2008. — Vol. 15(4). — P. 1048−1055.
- Parente J.T., Amsel M., Lerner R., Chinea F. Breast cancer associated with pregnancy// Obstet. Gynecol., 1988. Vol. 71. — P. 861−864.
- Park M., Oh К., Kim E. et al. Multifaces of sonografic findings of galactocele: comparison accoding to its association with pregnancy // J. Korean Radiol. Soc., 2000. Vol. 42. — P. 699−703.
- Patridge A.H., Gerber J.E. Long-term outcomes of children exposed to antineoplastic agents in utero (review) // Seminars in Oncology, 2000. Vol. 27(6). — P. 712−726.
- Partridge A., Schapira L. Pregnancy and breast cancer: epidemiology, treatment, and safety issues // Oncology (Williston Park), May 2005. Vol. 19 (6). — P. 693−697.
- Pavlidis N., Pentheroudakis G. The pregnant mother with breast cancer: diagnostic and therapeutic management // Cans. Treat Reviews, 2005. Vol. 31. — P. 439−447.
- Pavlidis N. Metastatic involvement of placenta and foetus in pregnant women with cancer // ESO Course, Orta, Nov. 2006.
- Pedersen H., Finster M. Anesthetic risk in the pregnant surgical patient // Anesthesiology, 1979. Vol. 51. — P. 439−451.
- Pelsang R. Diagnostic imaging modalities during pregnancy // Obstet Gynecol. Clin. North Am., 1998. Vol. 25. — P. 287−300.
- Pentheroudakis G., Pavlidis N. Cancer and Pregnancy: poena magna, not anymore // Eur. J. Cancer, 2006. Vol. 12. — P. 126−140.
- Peters M. Factor of pregnancy in breast cancer // Prognostic factors in breast cancer, Edinburg, 1968. P. 74−95.
- Peters M. The effect of pregnancy in breast cancer // Forrest АРМ, Kunkler P.B., eds. Baltimore: Williams and Wilkins, 1968. P. 65−80.
- Peters V.M., Meakin J.W. The influence of pregnancy in carcinoma of the breast // Prog. Clin. Cancer, 1965. Vol. 1. — Pp. 471.
- Petrek J., Dukoff R., Rogatko A. Prognosis of pregnancy-associated breast cancer// Cancer, 1991. Vol. 67. — P. 869−872.
- Petrek J. Breast cancer during pregnancy // Cancer, 1994. Vol. 74(1). — P. 518−527.
- Petrek J.A. Breast cancer and pregnancy In: Harris, JR, Morrow M, Lippman ME, et al.eds. // Diseases of the Breast. Lippincott-Raven Publishers: Philadelphia. -1996.-P. 883−892.
- Petrek J. Safety of pregnancy after breast cancer: are the data reliable? editorial. // Medscape Women’s Health Journal, 1997. Vol. 2.
- Petrek J.A. Abnormalities of the breast in pregnancy and lactation // In: Diseases of the Breast, 2nd ed. Edited by Jay R. Harris, Lippincot, Philadelphia, Chapter 7. 2000. — P.63−66.
- Petrek J., Theriault L. Pregnancy-associated breast cancer and subseguent pregnancy in breast cancer survivors // Monogr. «Diseases of the Breast» Third edition, 2004. P. 1035−1046.
- Petrek J., Naughton M., Case L. et al. Incidence, time course, and determinants of menstrual bleeding after breast cancer treatment: a prospective study // J. Clin. Oncol., 2006. Vol. 24. — № 7. — P. 1045−1051.
- Pisarska M., Ka о Lee-Chuan. Can ovarian function be protected in young women receiving chemotherapy? // Nature Clinical Practice Oncology, 2006. — Vol. 3.-P. 532−533.
- Poirot C., Vacher-Lavenu M.C., Helardot P. et al. Human ovarian tissue cryopreservation: Indications and feasibility // Hum. Reprod., 2002. — Vol. 17. — P. 1447−1452.
- Polyak K. Pregnancy and breast cancer: the other side of coin // Cancer Cell, March 2006.-Vol. 9(3).-P. 151−153.
- Poniecka A.W., Krasuski P., Gal E., Lubin J., Howard L., Poppiti R.J. Granulomatous inflammation of the breast in a pregnant woman: report of a case with fine needle aspiration diagnosis // Acta Cytol., 2001. Vol. 45. — P. 797−801.
- Potter J.F., Schoeneman M. Metastases of maternal cancer to the placenta and fetus // Cancer, 1970. Vol. 25. — P. 380−388.
- Radford J.A., Lieberman В.A., Brison D.R. et al. Orthotopic reimplantation of cryopreserved ovarian cortical strips after high-dose chemotherapy for Hodgkin’s lymphoma // Lancet, 2001. Vol. 357. — P. 1172−1175.
- Rebbeck Т., Friebel Т., Lynch H. et al. Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group // J. Clin. Oncol., Mar 15 2004. Vol. 22 (6). — P. 1055−1062.
- Reiem K., Flucke U., Engel C. et al. Associated of BRCA1 missense variant R1699W with a malignant phyllodes tumor of the breast // Cancer Genetics and Cytogenetics, 2007. Vol. 176. — P. 76−79.
- Ribeiro G.G., Palmer M.K. Breast cancer associated with pregnancy: clinicians' dilemma//BMJ, 1977.-Vol. 2.-P. 1524−1527.
- Ribeiro G., Jones D., Jones M. Carcinoma of the breast associated with pregnancy // Br. J. Surg., 1986. Vol. 73. — P. 607−609.
- Ricci E., Parazzinil F., Negri IE. et al. Fertility drugs and the risk of breast cancer//Human Reproduction, 1999.-Vol. 14.-№ 6.-P. 1653−1655.
- Rissanen P. Carcinoma of the breast during pregnancy and lactation // Brit. J. Cancer, 1968. Vol. 22. — P. 663−668.
- Rissanen P.M. Pregnancy following treatment of mammary carcinoma // Acta Radiol. Ther. Phys. Biol., 1969. Vol. 8. — P. 415−422.
- Rosemond G. Carcinoma of the breast during pregnancy // Clin. Obstet. Cynecol., 1963.-Vol. 6. P. 994−1001.
- Rosemond G. Management of patients with carcinoma of the breast in pregnancy // Ann. N-Y. Acad. Sci., 1964. Vol. 114. — P. 851 -856.
- Rosenkranz K.M., Lucci A. Surgical treatment of pregnancy associated breast cancer // Breast Dis., 2006. Vol. 23. — P. 87−93.
- Rosner D., Yeh J. Breast cancer and related pregnancy: suggested management according to stages of the disease and gestational stages // J. of Med., 2002. Vol. 33.-№ 1−4.-P. 23−54.
- Rossing M.A., Daling J.R., Weiss N.S. et al. Risk of breast cancer in a cohort of infertile women// Gynecol. Oncol., 1996. Vol. 60. — P. 3−7.
- Rothman L.A., Cohen C.J., Astarloa J. Placenta and fetal involvement by maternal malignancy: a report of rectal carcinoma and review of the literature // Am. Obstet. Gynecol., 1973.-Vol. 116.-P. 1023−1034.
- Russo I.H., Russo J. // IV Europ Congress on menopause. Eds M. Birkhauser, H. Rosenbaum — Vienna, ESKA, 1998. — P. 133−142.
- Russo I.H., Russo J. In the Progress in the management of the menopause. — BG Wren (td-r). The Parthenon Publist. 1996. — Pp. 184−193.
- Russo J., Balogh G., Russo I.H. Breast cancer prevention // Climacteric, Oct. 10 2007.-Vol. 2.-P. 47−53.
- Russo J., Balogh G.A., Russo I.H. Full-term pregnancy induces a specific genomic signature in the human breast // Cancer Epidemiol. Biomarkers Prev., Jan 2008.-Vol. 17(1).-P. 51−66.
- Salvadori В., Cusumano F., Del Bo R. Argomenti oncol.- 1th ed.-UFO.-1990.-P.157−163.
- Samuels Т.Н., Liu F.F., Yaffe M. et al. Gestational breast cancer // Can. Assoc. Radiol. J, 1998. Vol. 48. — P. 172−180.
- Sanderson M., Williams M., Malone K. et al. Perinatal factors and risk of breast cancer // Epidemiology, 1995. Vol. 7. — P. 34−37.
- Sankila R., Heinavaara S., Hakulinen T. Survival of breast cancer patients after subsequent term pregnancy: «healthy mother effect» // Am. J. Obstet. Gynecol., 1994, — Vol. 170.-P. 818−823.
- Sawhney S., Petrovska L., Ramadan S. et al. Sonographic appearances of galactoceles // J. Clin. Ultrasound, 2002. Vol. 30. — P. 18−22.
- Salazar H, Tobon H: Morphologic changes of the mammary gland during development, pregnancy and lactation. / Lactogenic Hormones, Fetal Nutrition and Lactation (Josimovich J, ed). New York: Wiley, — 1974. — P.221 -277
- Schackmuth E.M., Harlow C.L., Norton L.W. Milk fistula: a complication after core breast biopsy // Am. J. Roentgenol., 1993. Vol. 161. — P. 790−794.,
- Schapira D.V., Chudley A.E. Successful pregnancy following continuous treatment with combination chemotherapy before conception and throughout pregnancy // Cancer, 1984. Vol. 54. — P. 800−803.
- Semmens I, Saunders C, Puckridge P. A growing dilemma-breast cancer and pregnancy // Aust Fam Physician, 2002. -Vol. 31. P. 929−932.
- Scott R., Toner J., Muasher S. et al. FSH levels on cycle day 3 are predictive of IVF outcome//Fertil Steril, 1989.-Vol. 51.-P. 651−654.
- Scott-Connor C., Schorr S. The diagnosis and management of breast problems during pregnancy and lactation // Am. J. Surg., 1995. Vol. 170. — P. 401−405.
- Selevan S.G., Lindbohm M.L., Hornung R.W. A study of occupational explosure to antineoplasyic drugs and fetal loss in nurses // N. Engl. J. Med., 1985. -Vol. 313.-P. 1173−1178.
- Shahin M., Sorosky J. The use of antineoplastic agents in pregnancy. In: Yankowitz J, Niebyl J, eds. // Drug Therapy in Pregnancy. 3rd ed. Philadelphia, Pa: Lippincott Williams & Wilkins, 2001- P. 205−214.
- Shakhar К., Valdimarsdottir H.B., Bovbjerg D.H. Heightened risk of breast cancer following pregnancy: could lasting systemic immune alterations contribute? // Cancer Epidemiol. Biomarkers Prev., Jun 2007. Vol. 16 (6). — P. 1082−1086.
- Shannon J., Douglas-Jones A.G., Dallimore N.S. Conversion to core biopsy in preoperative diagnosis of breast lesions: is it justified by results? // J. Clin. Pathol., 2001.-Vol. 54.-P. 762−765.
- Shen Т., Vortmeyer A.O., Zhuang Z., Tavassoli F.A. High frequency of allelic loss of BRCA2 gene in pregnancy-associated breast carcinoma // J. Natl. Cancer Inst., 1999.-Vol. 91.-P. 1686−1687.
- Shi S.O., Xu L., Zhao G. et al. Apoptosis and tumor inhibition induced by human chorionic gonadotropin beta in mouse breast carcinoma // J.Mol.Med., 2006. Nov.-Vol. 84 (11)-P. 933−941.
- Stephens JD, Golbus MS, Miller TR, Wilber RR, Epstein CJ. Multiple congenital anomalies in a fetus exposed to 5-fluorouracil during the first trimester // Am J Obstet Gynecol., 1980. Vol. 137-P. 747−749.
- Sutton R., Buzdar A.U., Hortobagyi G.N. Pregnancy and offsping after adjuvant chemotherapy in breast cancer patients // Cancer, 1990. Vol. 65. — P. 847 850.
- Sweet D.L., Kinzie J. Consequences of radiotherapy and antineoplastic therapy for the fetus // J. Reprod. Med., 1976. Vol. 17. — P. 241−246.
- Tancini G., Valagussa P., et al. Preliminary 3-year results of 12 versus 6 cycles of surgical adjuvant CMF in premenopausal breast cancer // Cancer Clin. Trials, 1979. -Vol. 14:115 abst.158.
- Tavani A., Gallus S., La Vecchia C. et al. Risk factors for breast cancer in women under 40 years // Eur. J. Cancer, 1999. Vol. 35(9). — P. 1361−1367.
- Tretli S, Kvalheim G, Thoresen S, Host H. Survival of breast cancer patients diagnosed during pregnancy or lactation // Br. J. Cancer, 1988. Vol. 58. — P. 382 384.
- Trichopoulos D. Hypothesis: does breast cancer originate in utero? // Lancet, 1990.-Vol. 335.-P. 939−940.
- Vatten L. J, Kvinnsland S. Pregnancy-related factors and risk of breast cancer in a prospective study of 29, 981 Norwegian women // Eur. J. Cancer, 1992. Vol. 28A.-P. 1148−1153.
- Venn A, Watson L, Lumley J, Giles G, King C, Healy D. Breast and ovarian cancer incidence after infertility and in vitro fertilization // Lancet, Oct 14 1995.-Vol. 346 (8981).-P. 995−1000.
- Verentgas P, Dailing J.R. Malone K.E. et al. Pregnancy after breast carcinoma outcomes and influence on mortality // Cancer, 1999. Vol. 85. — P. 2424−2432.
- Verhoog L, Brekelmans C. et al. Survival and tumor haracteristics of hreast cancer patients it. with gennline mutations of BRCA 1 // Lancet, 1998. Vol. 35.-P. 316−321.
- Von Schoultz E, Johansson H, Wilking N. et al. Influence of prior and subsequent pregnancy on breast cancer prognosis // J. Clin. Oncol, 1995. — Vol. 13. — p. 430−434.
- Walshe J, Denduluri N, Swain S. Amenorrhea in Premenopausal Women After Adjuvant Chemotherapy // Breast Cancer Journal of Clinical Oncology, Dec. 20 2006. Vol. 24. — № 36. — P. 5769−5779.
- Wallack MK, Wolf JA, et al. Gestational carcinoma of the female breast // Curr Probl Cancer, 1983. Vol. 7. — P. 3−58.
- Weber В., Luporsi E. Ovarian toxicity of breast cancer chemotherapy // Eur. J. Cancer, 1998. Vol. 34(5). — Pp. 42.
- Weibe V.J., Sipila P.E.N. Pharmacology of antineoplastic agents in pregnancy // Crit. Rev. Oncol. Hematol., 1994. Vol. 16. -P. 75−112.
- Weier N., He S.M., Li X.T., Wang L.L., Zhou S.F. Placental drug disposition and its clinical implications // Curr. Drug. Metab., Feb 2008. Vol. 9 (2). — P. 106 121.
- Westenend P.J., Sever A.R., Beekman-De Voider H.J., Liem S.J. A comparison of aspiration cytology and core needle biopsy in the evaluation of breast lesions // Cancer, 2001.-Vol. 93.-P. 146−150.
- White T.T. Carcinoma of the breast and pregnancy // Ann. Surg., 1954. Vol. 139.-Pp. 9.
- White T.T. Prognosis for breast cancer for pregnant and nursing women: Analysis of 1413 cases // Surg. Gynecol. Obstet., 1955. Vol. 100. — P. 661−666.
- Williams E., Jones L., Vessey M.P. et al. Short term increase in risk of breast cancer associated with full term pregnancy // BMJ, 1990. Vol. 300. — P. 578−579.
- Williams S., Schilsky R. Antineoplastic drugs administered during pregnancy // Semin. Oncol., 2000. Vol. 27. — P. 618−622.
- Williams W. et al. Cancer of the male breast based on tbe records of 100 cases //Lancet, 1889.-Vol. 2.-P. 261.
- Williams W., Anderson D. Genetic epidemiologi of breast cancer analysis of 200 Danish pedigrees // Genet. Epidm., 1984. Vol. 1. — P. 7−20.
- Wohlfahrt J., Melbye M. Age at any birth is associated with breast cancer risk //Epidemiology, 2001.-Vol. 12.-№ l.-P. 68−73.
- Woo J.C., Yu Т., Hurd T.C. Breast cancer in pregnancy // Arch. Surg., 2003. -Vol. 138.-P. 91−98.
- Young R.H., Scully R. Metastatic tumours of the ovary // In Kurman R.J. (ed.), Blaustein Patology of the Female Genital Tract, 4th edition, New York, 1994, — P. 939 974.